A method for treating azoospermia consists of lowering a patient's testosterone for an extended duration in order to induce spermatogonia stem cell function to produce spermatozoa. The patient's testosterone is reduced through the incorporation of glycyrrhiza glabra in three medicinal mixtures. A first medicinal mixture is used to lower testosterone in the patient as the first medicinal mixture is primarily glycyrrhiza glabra, and the first medicinal mixture is administered for at least one month. The quantity of glycyrrhiza glabra is reduced in administration of the second medicinal mixture over at least two months, subsequent to the first medicinal mixture. The quantity of glycyrrhiza glabra is further reduced in administration of the third medicinal mixture over at least three months, subsequent to the second medicinal mixture. A plurality of additional ingredients is included in the second medicinal mixture and the third medicinal mixture in order to promote spermatozoa production and virility.
